Evidence map›Paper›PMID 20620143›Full record

ArticleInternational journal for parasitology2010

Quantitative and qualitative features of heterologous virus-vector-induced antigen-specific CD8+ T cells against Trypanosoma cruzi infection.

Eiji Takayama, Takeshi Ono, Elena Carnero, Saori Umemoto, Yoko Yamaguchi, Atsuhiro Kanayama, Takemi Oguma, Yasuhiro Takashima, Takushi Tadakuma, Adolfo García-Sastre and 1 more

Open access · greenAbstract read
In one paragraph

Article in International journal for parasitology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Eiji TakayamaDepartment of Global Infectious Diseases and Tropical Medicine, National Defense Medical College, Tokorozawa City, Saitama, Japan.
Takeshi Ono
Elena Carnero
Saori Umemoto
Yoko Yamaguchi
Atsuhiro Kanayama
Takemi Oguma
Yasuhiro Takashima
Takushi Tadakuma
Adolfo García-Sastre
Yasushi Miyahira
National Defense Medical College · JPIcahn School of Medicine at Mount Sinai · USGifu University · JP

Funding

Live attenuated vaccines for epidemic and pandemic fluU01AI070469 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GARCIA-SASTRE, ADOLFO · 2006 to 2010
$9.7M
NIAID NIH HHS U01 AI070469NIAID NIH HHS U01AI70469
6 · The paper itself

Abstract

We studied some aspects of the quantitative and qualitative features of heterologous recombinant (re) virus-vector-induced, antigen-specific CD8(+) T cells against Trypanosoma cruzi. We used three different, highly attenuated re-viruses, i.e., influenza virus, adenovirus and vaccinia virus, which all expressed a single, T. cruzi antigen-derived CD8(+) T-cell epitope. The use of two out of three vectors or the triple virus-vector vaccination regimen not only confirmed that the re-vaccinia virus, which was placed last in order for sequential immunisation, was an effective booster for the CD8(+) T-cell immunity in terms of the number of antigen-specific CD8(+) T cells, but also demonstrated that (i) the majority of cells exhibit the effector memory (T(EM)) phenotype, (ii) robustly secrete IFN-γ, (iii) express higher intensity of the CD122 molecule and (iv) present protective activity against T. cruzi infection. In contrast, placing the re-influenza virus last in sequential immunisation had a detrimental effect on the quantitative and qualitative features of CD8(+) T cells. The triple virus-vector vaccination was more effective at inducing a stronger CD8(+) T-cell immunity than using two re-viruses. The different quantitative and qualitative features of CD8(+) T cells induced by different immunisation regimens support the notion that the refinement of the best choice of multiple virus-vector combinations is indispensable for the induction of a maximum number of CD8(+) T cells of high quality.

Indexed as

Genetic VectorsAdenoviridaeAnimalsAntigens, ProtozoanCD8-Positive T-LymphocytesChagas DiseaseEpitopes, T-LymphocyteFemaleImmunization, SecondaryImmunologic MemoryInterferon-gammaInterleukin-2 Receptor beta SubunitMiceOrthomyxoviridaeProtozoan VaccinesRecombinant ProteinsAntigens, ProtozoanEpitopes, T-LymphocyteInterferon-gammaInterleukin-2 Receptor beta SubunitProtozoan VaccinesRecombinant Proteins

Identifiers

PMID20620143
PMCPMC2952726
OpenAlexW2058214454

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.